Author

Kayla Marie Lazzara

Observed name: Kayla M. Lazzara

Institutions: Indiana University Health, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University

Observed institutions: Indiana University Health, Indiana University Indianapolis, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University

OpenAlex ID: A5069458164

Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors

2021 · Ryan Ashkar, Darren R. Feldman, et al. · Investigational New Drugs · 16

Clinical course of patients with cisplatin (CDDP)-associated neuropathy compared to other neurotoxic chemotherapy.

2019 · Costantine Albany, Travis Dockter, et al. · Journal of Clinical Oncology · 2

Hypogonadism and effects on quality of life in previously treated germ cell tumor survivors: A single-centre, non-randomized, prospective observational study.

2018 · Nabin Khanal, Maitri Kalra, et al. · Journal of Clinical Oncology · 1

Works count: 3

Citation count: 19

H-index: 2

I10-index: 1